Cargando…

Analyzing breast cancer invasive disease event classification through explainable artificial intelligence

INTRODUCTION: Recently, accurate machine learning and deep learning approaches have been dedicated to the investigation of breast cancer invasive disease events (IDEs), such as recurrence, contralateral and second cancers. However, such approaches are poorly interpretable. METHODS: Thus, we designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Massafra, Raffaella, Fanizzi, Annarita, Amoroso, Nicola, Bove, Samantha, Comes, Maria Colomba, Pomarico, Domenico, Didonna, Vittorio, Diotaiuti, Sergio, Galati, Luisa, Giotta, Francesco, La Forgia, Daniele, Latorre, Agnese, Lombardi, Angela, Nardone, Annalisa, Pastena, Maria Irene, Ressa, Cosmo Maurizio, Rinaldi, Lucia, Tamborra, Pasquale, Zito, Alfredo, Paradiso, Angelo Virgilio, Bellotti, Roberto, Lorusso, Vito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932275/
https://www.ncbi.nlm.nih.gov/pubmed/36817766
http://dx.doi.org/10.3389/fmed.2023.1116354
_version_ 1784889418825334784
author Massafra, Raffaella
Fanizzi, Annarita
Amoroso, Nicola
Bove, Samantha
Comes, Maria Colomba
Pomarico, Domenico
Didonna, Vittorio
Diotaiuti, Sergio
Galati, Luisa
Giotta, Francesco
La Forgia, Daniele
Latorre, Agnese
Lombardi, Angela
Nardone, Annalisa
Pastena, Maria Irene
Ressa, Cosmo Maurizio
Rinaldi, Lucia
Tamborra, Pasquale
Zito, Alfredo
Paradiso, Angelo Virgilio
Bellotti, Roberto
Lorusso, Vito
author_facet Massafra, Raffaella
Fanizzi, Annarita
Amoroso, Nicola
Bove, Samantha
Comes, Maria Colomba
Pomarico, Domenico
Didonna, Vittorio
Diotaiuti, Sergio
Galati, Luisa
Giotta, Francesco
La Forgia, Daniele
Latorre, Agnese
Lombardi, Angela
Nardone, Annalisa
Pastena, Maria Irene
Ressa, Cosmo Maurizio
Rinaldi, Lucia
Tamborra, Pasquale
Zito, Alfredo
Paradiso, Angelo Virgilio
Bellotti, Roberto
Lorusso, Vito
author_sort Massafra, Raffaella
collection PubMed
description INTRODUCTION: Recently, accurate machine learning and deep learning approaches have been dedicated to the investigation of breast cancer invasive disease events (IDEs), such as recurrence, contralateral and second cancers. However, such approaches are poorly interpretable. METHODS: Thus, we designed an Explainable Artificial Intelligence (XAI) framework to investigate IDEs within a cohort of 486 breast cancer patients enrolled at IRCCS Istituto Tumori “Giovanni Paolo II” in Bari, Italy. Using Shapley values, we determined the IDE driving features according to two periods, often adopted in clinical practice, of 5 and 10 years from the first tumor diagnosis. RESULTS: Age, tumor diameter, surgery type, and multiplicity are predominant within the 5-year frame, while therapy-related features, including hormone, chemotherapy schemes and lymphovascular invasion, dominate the 10-year IDE prediction. Estrogen Receptor (ER), proliferation marker Ki67 and metastatic lymph nodes affect both frames. DISCUSSION: Thus, our framework aims at shortening the distance between AI and clinical practice
format Online
Article
Text
id pubmed-9932275
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99322752023-02-17 Analyzing breast cancer invasive disease event classification through explainable artificial intelligence Massafra, Raffaella Fanizzi, Annarita Amoroso, Nicola Bove, Samantha Comes, Maria Colomba Pomarico, Domenico Didonna, Vittorio Diotaiuti, Sergio Galati, Luisa Giotta, Francesco La Forgia, Daniele Latorre, Agnese Lombardi, Angela Nardone, Annalisa Pastena, Maria Irene Ressa, Cosmo Maurizio Rinaldi, Lucia Tamborra, Pasquale Zito, Alfredo Paradiso, Angelo Virgilio Bellotti, Roberto Lorusso, Vito Front Med (Lausanne) Medicine INTRODUCTION: Recently, accurate machine learning and deep learning approaches have been dedicated to the investigation of breast cancer invasive disease events (IDEs), such as recurrence, contralateral and second cancers. However, such approaches are poorly interpretable. METHODS: Thus, we designed an Explainable Artificial Intelligence (XAI) framework to investigate IDEs within a cohort of 486 breast cancer patients enrolled at IRCCS Istituto Tumori “Giovanni Paolo II” in Bari, Italy. Using Shapley values, we determined the IDE driving features according to two periods, often adopted in clinical practice, of 5 and 10 years from the first tumor diagnosis. RESULTS: Age, tumor diameter, surgery type, and multiplicity are predominant within the 5-year frame, while therapy-related features, including hormone, chemotherapy schemes and lymphovascular invasion, dominate the 10-year IDE prediction. Estrogen Receptor (ER), proliferation marker Ki67 and metastatic lymph nodes affect both frames. DISCUSSION: Thus, our framework aims at shortening the distance between AI and clinical practice Frontiers Media S.A. 2023-02-02 /pmc/articles/PMC9932275/ /pubmed/36817766 http://dx.doi.org/10.3389/fmed.2023.1116354 Text en Copyright © 2023 Massafra, Fanizzi, Amoroso, Bove, Comes, Pomarico, Didonna, Diotaiuti, Galati, Giotta, La Forgia, Latorre, Lombardi, Nardone, Pastena, Ressa, Rinaldi, Tamborra, Zito, Paradiso, Bellotti and Lorusso. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Massafra, Raffaella
Fanizzi, Annarita
Amoroso, Nicola
Bove, Samantha
Comes, Maria Colomba
Pomarico, Domenico
Didonna, Vittorio
Diotaiuti, Sergio
Galati, Luisa
Giotta, Francesco
La Forgia, Daniele
Latorre, Agnese
Lombardi, Angela
Nardone, Annalisa
Pastena, Maria Irene
Ressa, Cosmo Maurizio
Rinaldi, Lucia
Tamborra, Pasquale
Zito, Alfredo
Paradiso, Angelo Virgilio
Bellotti, Roberto
Lorusso, Vito
Analyzing breast cancer invasive disease event classification through explainable artificial intelligence
title Analyzing breast cancer invasive disease event classification through explainable artificial intelligence
title_full Analyzing breast cancer invasive disease event classification through explainable artificial intelligence
title_fullStr Analyzing breast cancer invasive disease event classification through explainable artificial intelligence
title_full_unstemmed Analyzing breast cancer invasive disease event classification through explainable artificial intelligence
title_short Analyzing breast cancer invasive disease event classification through explainable artificial intelligence
title_sort analyzing breast cancer invasive disease event classification through explainable artificial intelligence
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932275/
https://www.ncbi.nlm.nih.gov/pubmed/36817766
http://dx.doi.org/10.3389/fmed.2023.1116354
work_keys_str_mv AT massafraraffaella analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT fanizziannarita analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT amorosonicola analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT bovesamantha analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT comesmariacolomba analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT pomaricodomenico analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT didonnavittorio analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT diotaiutisergio analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT galatiluisa analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT giottafrancesco analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT laforgiadaniele analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT latorreagnese analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT lombardiangela analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT nardoneannalisa analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT pastenamariairene analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT ressacosmomaurizio analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT rinaldilucia analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT tamborrapasquale analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT zitoalfredo analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT paradisoangelovirgilio analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT bellottiroberto analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence
AT lorussovito analyzingbreastcancerinvasivediseaseeventclassificationthroughexplainableartificialintelligence